Quest Diagnostics has grown revenue 6.8% a year over three years and 0.89% a year over five, with earnings per share compounding at 11%. Revenue growth, 3-year annual rate: +6.8% (Diagnostics & Research median +8.4%). Revenue growth, 5-year rate: +0.89%, growth has picked up over the last three years. Earnings per share, 3-year rate: +11%, earnings outgrew revenue: margins or the share count worked for shareholders. Years of annual history on file: 19, FY2007 to FY2025, as filed.

DGXQuest Diagnostics

Healthcare

$231.15+28% 1Y

$231.15

$171.9552 weeks$247.58

Is it growing?

Mixed

Neither accelerating nor breaking down: nothing decisive, though earnings up +13% year on year.

1 good, 2 neutral

Revenue trend+10% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +1% a year.

Earnings trend+13% in a year

Trailing-twelve-month earnings per share against a year earlier. Growing faster than revenue, so margins or the share count are helping.

Margin direction+0.1 points operating

Trailing-twelve-month operating margin, 14.1% now against 14.0% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

Revenue growth, 3 yearsmiddle of the market

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is DGX growing?

Quest Diagnostics has grown revenue 6.8% a year over three years and 0.89% a year over five, with earnings per share compounding at 11%.

+6.8%

Revenue growth, 3-year annual rate · Diagnostics & Research median +8.4% · steady growth, ahead of inflation · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +0.89%
Revenue growth, 5-year rate · +6.8% over three · growth has picked up over the last three years
Earnings per share, 3-year rate: +11%
Earnings per share, 3-year rate · revenue +6.8% · earnings outgrew revenue: margins or the share count worked for shareholders
Years of annual history on file: 19
Years of annual history on file · FY2007 to FY2025, as filed